UNSPSC 51342902: Famciclovir

This classification denotes a purine antagonist and antiviral agent with the molecular formula C14H19N5O4, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier QIC03ANI02, chemically known as 1,3-propanediol, 2-(2-(2-amino-9h-purin-9-yl)ethyl)-, diacetate (ester) but generally known as famciclovir, which bears US NIH Compound Identifier 3324. European Medicines Agency schedules Famciclovir in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07501MIG.

UNSPSC 51342902 Famciclovir is a Commodity code for an antiviral pharmaceutical product, but recent state and local contract activity under this code shows little relevance to famciclovir itself. The two most recent opportunities posted in the source—an Illinois Department of Public Health piggyback pharmaceutical award in August 2026 for Doxycycline Hyclate and Ciprofloxacin Hydrochloride, and a Seminole County, Florida Invitation for Bid in June 2026 for Naloxone and drug deactivation systems—both address public health supply chains but neither involves famciclovir or antiviral medications. State and local procurement activity under this code appears sparse or mislabeled; the opportunities named do not align with the commodity's nominal scope.

Geographic activity on record is limited to Illinois and Florida. The Illinois Department of Public Health awarded a three-year pharmaceutical warehouse piggyback contract through MMCAP Infuse to Chartwell Rx LLC for $2,999,999.11, selecting the vendor as lowest priced responsive bidder under an Invitation for Bid process. Seminole County released an IFB in June 2026 (with response deadline July 26, 2023—note the date inconsistency in source) for annual supplies of 1,900 units of Naloxone and 800 Safe Drug Deactivation Systems with quarterly delivery to the Seminole County Community Health Building in Sanford, Florida. Neither opportunity explicitly targets antiviral pharmaceuticals or demonstrates sustained procurement activity under the famciclovir code.